1971. A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Tolerability of a Respiratory Syncytial Virus (RSV) Neutralizing Monoclonal Antibody (MK-1654) in Healthy Subjects-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

1971. A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Tolerability of a Respiratory Syncytial Virus (RSV) Neutralizing Monoclonal Antibody (MK-1654) in Healthy Subjects

Published:2018-11 Issue:suppl_1 Volume:5 Page:S572-S572
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Aliprantis Antonios¹,Wolford Dennis¹,Caro Luzelena¹,Maas Brian¹,Ma Hua¹,Vora Kalpit¹,Geng Dong¹,Railkar Radha¹,Lee Andrew¹,Sterling Laura²,Lai Eseng¹

Affiliation:

1. Merck & Co., Inc., Kenilworth, NJ

2. Celerion, West Conshohocken, Pennsylvania

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Link

http://academic.oup.com/ofid/article-pdf/5/suppl_1/S572/27562561/ofy210.1627.pdf

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccines for the common cold;Cochrane Database of Systematic Reviews;2022-12-14

2. The Future of Respiratory Syncytial Virus Disease Prevention and Treatment;Infectious Diseases and Therapy;2021-03

3. Nirsevimab: An Extended Half-life Monoclonal Antibody for the Prevention of Infant Respiratory Syncytial Virus Infection;US Respiratory & Pulmonary Diseases;2021

4. Current State and Challenges in Developing Respiratory Syncytial Virus Vaccines;Vaccines;2020-11-11

5. Preventive Strategies for Respiratory Syncytial Virus Infection in Young Infants;NeoReviews;2020-08-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP